The biotechnology company Theranos has been consistently appearing across newspaper and magazine headlines over the past few years (1–3). In 2014, the firm's then 30-year-old founder, charismatic Stanford-dropout Elizabeth Holmes, began to receive tremendous amounts of media attention (1–4). She was trumpeted as a visionary as she proclaimed her plan to revolutionize blood testing (2). Her company garnered hundreds of millions of dollars following her claim that Theranos had designed a system to run hundreds of tests on a miniscule amount of blood drawn via finger prick (3). The company, partnered with Walgreens (a major American drug store chain), began opening Theranos Wellness Centers where individuals could order their own tests and seemed poised to completely disrupt the traditional blood testing industry (2).

However, in October 2015, Wall Street Journal investigative journalist John Carreyrou began to uncover the truth behind Theranos's claims (5). In a series of shattering revelations, the public learned that not only was Theranos's technology weak but also that Holmes and her …

Log in using your username and password

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.